Literature DB >> 19183817

Measurement of problems in activities and participation in patients with anxiety, depression and schizophrenia using the ICF checklist.

Rosalía Tenorio-Martínez1, María del Carmen Lara-Muñoz, María Elena Medina-Mora.   

Abstract

BACKGROUND: Although disability in persons with anxiety and depression disorders has been measured, the problem with some studies is that they use tools that measure the state of health, when the subjective nature of the measuring system does not permit the exact measurement of disability. The ICF Checklist provides a new paradigm for measuring disability that focuses more on the consequences than on the illness itself. The objective of this study is to compare the problems in Activities and Participation observed in patients with anxiety, depressive, and schizophrenic disorders, using the ICF Checklist.
METHODS: The ICF Checklist was administered to 72 patients with anxiety or depressive disorders and 28 patients with schizophrenia. They were diagnosed in accordance with the criteria of the ICD-10. Chi-square analysis was carried out to determine the differences between the groups studied with respect to the Activities and Participation scales of the ICF Checklist and the nominal data of the socio-demographic variables.
RESULTS: The group with anxiety-depression had a higher percentage of patients with problems preparing meals (30.6%) and achieving intimate relationships (59.7%) than did the patients with schizophrenia. The group with schizophrenia had a higher percentage of patients who had problems watching (39.3%), listening (42.9%), undertaking a single task (60.7%), communicating, fine hand use (57.1%), using transportation (64.3%), and caring for body parts (67.9%), among others.
CONCLUSIONS: The ICF Checklist permits comparison of the impact mental disorders have on patients. It provides a more appropriate way of evaluating these illnesses in relation to others, considering not only the question of mortality but also the years lived with disability due to illness.

Entities:  

Mesh:

Year:  2009        PMID: 19183817     DOI: 10.1007/s00127-008-0449-3

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  30 in total

Review 1.  Measuring participation according to the International Classification of Functioning, Disability and Health (ICF).

Authors:  Rom J M Perenboom; Astrid M J Chorus
Journal:  Disabil Rehabil       Date:  2003 Jun 3-17       Impact factor: 3.033

2.  ICF Core Sets for depression.

Authors:  Alarcos Cieza; Somnad Chatterji; Christina Andersen; Pedro Cantista; Malvina Herceg; John Melvin; Gerold Stucki; Rob de Bie
Journal:  J Rehabil Med       Date:  2004-07       Impact factor: 2.912

3.  The capacity of a measure of disability (the LSP) to predict hospital readmission in those with schizophrenia.

Authors:  G Parker; D Hadzi-Pavlovic
Journal:  Psychol Med       Date:  1995-01       Impact factor: 7.723

4.  Generalized anxiety and depression in primary care: prevalence, recognition, and management.

Authors:  Hans-Ulrich Wittchen; Ron C Kessler; Katja Beesdo; Petra Krause; Michael Höfler; Jürgen Hoyer
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

5.  P300 and disability of daily life in schizophrenia.

Authors:  A Iwanami; M Yamashina; H Kazamatsuri; K Kamijima
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1999-04       Impact factor: 5.067

6.  Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres.

Authors:  D Wiersma; J Wanderling; E Dragomirecka; K Ganev; G Harrison; W An Der Heiden; F J Nienhuis; D Walsh
Journal:  Psychol Med       Date:  2000-09       Impact factor: 7.723

7.  Psychosocial disability during the long-term course of unipolar major depressive disorder.

Authors:  L L Judd; H S Akiskal; P J Zeller; M Paulus; A C Leon; J D Maser; J Endicott; W Coryell; J L Kunovac; T I Mueller; J P Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  2000-04

Review 8.  Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment.

Authors:  N Brunello; J R Davidson; M Deahl; R C Kessler; J Mendlewicz; G Racagni; A Y Shalev; J Zohar
Journal:  Neuropsychobiology       Date:  2001       Impact factor: 2.328

9.  Measurement of social disability in a schizophrenic patient group. Definition, assessment and outcome over 2 years in a cohort of schizophrenic patients of recent onset.

Authors:  C Schubart; B Krumm; H Biehl; R Schwarz
Journal:  Soc Psychiatry       Date:  1986

10.  Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population.

Authors:  Lydia Fehm; Katja Beesdo; Frank Jacobi; Agnes Fiedler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-12-14       Impact factor: 4.328

View more
  1 in total

1.  Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort.

Authors:  Steve Brown; Clemence Mitchell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-05-11       Impact factor: 4.328

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.